Member Info for thomascromwell

Choleric, you have sold, so why waste your time posting?

In the coming year AxisB, should be generating substantial revenue and sales, and the reviews are fantastic. The Croda deal was signed and agreed upon in months, why has so much time elapsed for another deal to be concluded?

In the fast-paced world of probiotics, the CEO has to drive the company, the advantage of first mover is crucial and a deal must be made sooner rather than wait for the competition to catch up.

The several multi-national deals being tabled that Ashman has alluded to will ensure the company's resilience.

We have been in the dark as to a multi-national deal and Croda's rollout to their clients, if either is not forthcoming or NDC this would be a disappointment. Let's hope this is not the case!

.....................he is currently auditioning for ZZ Top.

Will there be a placing ahead of year-end results???????????

My Collie thinks that Opti is lost and Croda will buy at this price. If only AxisBiotixs had a flea remedy.

How much debt is 8.5 BILLION?

Cineworld UK has 440million in assets and has 8.5 debt. The assets to be sold within this current year.

Shaza, I am not suggesting what you do with your money, but from your reply, you are a novice investor rebound in the price will not be happening as this is a zero mate.

Investors this is game over, do not commit your hard-earned to the dying embers of a company screwed by its management which has taken investors for a ride and left you all with f; all.

Look forward to the income from Croda being substantial and we are happily over 30p.

Why the f=ck are you still invested, bless you all.

3600 and increasing, order numbers for AxisB for the current year, bringing in a million plus not too bad from a standing start.

Thanks, for the calming effect. Reread the RNS and will once again watch Elric's podcast with rapt attention.

The silence is deafening from the company when the science works but the interest so far has either been illusionary or of real creditable interest. If as Stuart has suggested he has a multinational interest, why no RNS?

The lack of interest is more surprising, with the growing number of testimonials showing AxisBiotix is an effective treatment, are the associates of these societies really unaware of the product?

What I find dumbfounding is the negative reaction from both the UK and US Psoriasis Associations, when clearly AxisBiotix is showing results that would not be believed a year ago.

I wonder what the initial revenue from Croda might be!